Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Sells $260,725.02 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) SVP Mark Brosius sold 489 shares of the firm’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $533.18, for a total transaction of $260,725.02. Following the sale, the senior vice president now owns 2,091 shares of the company’s stock, valued at approximately $1,114,879.38. This represents a 18.95 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Mark Brosius also recently made the following trade(s):

• On Wednesday, March 5th, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $554.17, for a total transaction of $272,651.64.
• On Monday, March 3rd, Mark Brosius sold 492 shares of Intuitive Surgical stock. The stock was sold at an average price of $573.78, for a total transaction of $282,299.76.

Intuitive Surgical Trading Down 3.8 %

Shares of Intuitive Surgical stock opened at $518.26 on Monday. The firm has a market capitalization of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The firm’s 50 day moving average is $571.36 and its 200 day moving average is $531.85. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Intuitive Surgical by 1.1% during the 4th quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider’s stock valued at $16,813,478,000 after purchasing an additional 360,591 shares during the last quarter. State Street Corp grew its holdings in shares of Intuitive Surgical by 1.4% during the 3rd quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock valued at $7,393,673,000 after purchasing an additional 210,363 shares during the last quarter. FMR LLC grew its holdings in shares of Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock valued at $5,389,765,000 after purchasing an additional 838,793 shares during the last quarter. Geode Capital Management LLC boosted its position in Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider’s stock worth $4,039,200,000 after buying an additional 243,802 shares during the period. Finally, Fisher Asset Management LLC boosted its position in Intuitive Surgical by 1.8% during the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider’s stock worth $2,541,356,000 after buying an additional 86,488 shares during the period. 83.64% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of analysts have recently issued reports on ISRG shares. Royal Bank of Canada raised their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. Stifel Nicolaus raised their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, December 5th. Leerink Partners lifted their price objective on shares of Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank lifted their price objective on shares of Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Finally, Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price objective for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.